Autoimmune Hepatitis: Clinical Manifestations and Diagnostic Criteria

In 1998, the International Autoimmune Hepatitis Group - a panel of 40 hepatologists and hepatopathologists from 17 countries who have a particular interest in autoimmune hepatitis (AIH) - undertook a review, in light of subsequent experience, of the descriptive criteria and diagnostic scoring syst...

Full description

Bibliographic Details
Main Author: Ian G Mcfarlane
Format: Article
Language:English
Published: Hindawi Limited 2001-01-01
Series:Canadian Journal of Gastroenterology
Online Access:http://dx.doi.org/10.1155/2001/279637
id doaj-15cbbf606af94bf6aa21fcc1fd6c9437
record_format Article
spelling doaj-15cbbf606af94bf6aa21fcc1fd6c94372020-11-24T23:00:40ZengHindawi LimitedCanadian Journal of Gastroenterology0835-79002001-01-0115210711310.1155/2001/279637Autoimmune Hepatitis: Clinical Manifestations and Diagnostic CriteriaIan G Mcfarlane0Institute of Liver Studies, King’s College Hospital, Denmark Hill, London, UKIn 1998, the International Autoimmune Hepatitis Group - a panel of 40 hepatologists and hepatopathologists from 17 countries who have a particular interest in autoimmune hepatitis (AIH) - undertook a review, in light of subsequent experience, of the descriptive criteria and diagnostic scoring system that it had proposed in 1993 for the diagnosis of AIH. This review (published in 1999) noted that the original descriptive criteria appeared to be quite robust and required only relatively minor modifications to bring them up to date with developments and experience in diagnostic modalities for liver disease in general. Analysis of published data on the application of the original criteria in nearly 1000 patients revealed that the diagnostic scoring system had an overall diagnostic accuracy of 89.8%, with a sensitivity of 98.0%. Specificity for excluding definite AIH in patients with chronic viral hepatitis and circulating autoantibodies or patients with overlapping cholestatic syndromes was 98% to 100%, but specificity for excluding probable AIH in these disorders ranged from only 60% to 80%. Modifications, including adjustments to the weightings against biochemical and histological cholestatic features, have been made to the scoring system to improve its specificity.http://dx.doi.org/10.1155/2001/279637
collection DOAJ
language English
format Article
sources DOAJ
author Ian G Mcfarlane
spellingShingle Ian G Mcfarlane
Autoimmune Hepatitis: Clinical Manifestations and Diagnostic Criteria
Canadian Journal of Gastroenterology
author_facet Ian G Mcfarlane
author_sort Ian G Mcfarlane
title Autoimmune Hepatitis: Clinical Manifestations and Diagnostic Criteria
title_short Autoimmune Hepatitis: Clinical Manifestations and Diagnostic Criteria
title_full Autoimmune Hepatitis: Clinical Manifestations and Diagnostic Criteria
title_fullStr Autoimmune Hepatitis: Clinical Manifestations and Diagnostic Criteria
title_full_unstemmed Autoimmune Hepatitis: Clinical Manifestations and Diagnostic Criteria
title_sort autoimmune hepatitis: clinical manifestations and diagnostic criteria
publisher Hindawi Limited
series Canadian Journal of Gastroenterology
issn 0835-7900
publishDate 2001-01-01
description In 1998, the International Autoimmune Hepatitis Group - a panel of 40 hepatologists and hepatopathologists from 17 countries who have a particular interest in autoimmune hepatitis (AIH) - undertook a review, in light of subsequent experience, of the descriptive criteria and diagnostic scoring system that it had proposed in 1993 for the diagnosis of AIH. This review (published in 1999) noted that the original descriptive criteria appeared to be quite robust and required only relatively minor modifications to bring them up to date with developments and experience in diagnostic modalities for liver disease in general. Analysis of published data on the application of the original criteria in nearly 1000 patients revealed that the diagnostic scoring system had an overall diagnostic accuracy of 89.8%, with a sensitivity of 98.0%. Specificity for excluding definite AIH in patients with chronic viral hepatitis and circulating autoantibodies or patients with overlapping cholestatic syndromes was 98% to 100%, but specificity for excluding probable AIH in these disorders ranged from only 60% to 80%. Modifications, including adjustments to the weightings against biochemical and histological cholestatic features, have been made to the scoring system to improve its specificity.
url http://dx.doi.org/10.1155/2001/279637
work_keys_str_mv AT iangmcfarlane autoimmunehepatitisclinicalmanifestationsanddiagnosticcriteria
_version_ 1725641598894604288